V
Venkatesh Krishnamurthi
Researcher at Cleveland Clinic
Publications - 92
Citations - 2340
Venkatesh Krishnamurthi is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Nephrectomy & Transplantation. The author has an hindex of 24, co-authored 70 publications receiving 2164 citations.
Papers
More filters
Journal ArticleDOI
Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine.
Stuart M. Flechner,David A. Goldfarb,Charles S. Modlin,Jingyuan Feng,Venkatesh Krishnamurthi,Barbara Mastroianni,Kathy Savas,Daniel J. Cook,Andrew C. Novick +8 more
TL;DR: Calcineurin inhibitor drug avoidance with basiliximab induction and sirolimus provides comparable 1-year transplant outcomes, with significantly better renal function in primary renal allograft recipients.
Journal ArticleDOI
Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors
Emilio D. Poggio,Andrew D. Rule,Roberto Tanchanco,Susana Arrigain,Robert S. Butler,Titte R. Srinivas,B. Stephany,Kathryn H. Meyer,Saul Nurko,Richard Fatica,Daniel A. Shoskes,Venkatesh Krishnamurthi,David A. Goldfarb,Inderbir S. Gill,Martin Schreiber +14 more
TL;DR: It is shown that age and gender are important factors determining normal GFR in living kidney donors, and a significant doubling in the rate of GFR decline in donors over age 45 as compared to younger donors.
Journal ArticleDOI
The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.
Stuart M. Flechner,Lingmei Zhou,Ithaar Derweesh,Barbara Mastroianni,Kathy Savas,David A. Goldfarb,Charles S. Modlin,Venkatesh Krishnamurthi,Andrew C. Novick +8 more
TL;DR: During a 10-year period marked by changing recipient demographics, the introduction of MMF and SRL did not result in a significant increase in transplant wound-healing complications.
Journal ArticleDOI
Donor kidney volume and outcomes following live donor kidney transplantation.
Emilio D. Poggio,S. Hila,B. Stephany,Richard Fatica,Venkatesh Krishnamurthi,C. Del Bosque,David A. Goldfarb,Brian R. Herts,Vincent W. Dennis,Peter S. Heeger,William E. Braun +10 more
TL;DR: It is suggested that transplantation of larger kidneys confers an outcome advantage and larger kidneys should be preferred when selecting from otherwise similar living donors.
Journal ArticleDOI
Surgical resection of renal cell carcinoma after targeted therapy.
Anil A. Thomas,Brian I. Rini,Andrew J. Stephenson,Jorge A. Garcia,Amr Fergany,Venkatesh Krishnamurthi,Andrew C. Novick,Inderbir S. Gill,Eric A. Klein,Ming Zhou,Steven C. Campbell +10 more
TL;DR: Surgical resection of renal cell carcinoma after targeted therapy is feasible with low morbidity in most patients, however, significant complications can occur, raising concern for possible compromise of tissue and/or vascular integrity associated with surgery in this setting.